Business Daily from THE HINDU group of publications
Wednesday, Nov 15, 2006
ePaper


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Announcements
Web Extras - Pharmaceuticals
Zydus files application for obesity drug

Our Bureau

Ahmedabad , Nov 14

The Ahmedabad-based pharma major Cadila Healthcare Ltd (Zydus Cadila) has filed another IND (Investigational New Drug) application for the New Molecular Entity - ZYO1, a drug candidate for treating obesity and related disorders with the Drug Controller-General of India (DCGI).

ZYO1 is an experimental drug working through CB-1 mechanism, which will help obese patients lose weight, and also help in controlling blood sugar levels in type-2 diabetes. The drug could also have a role in protecting the heart, the company said in a release here.

The recently-concluded pre-clinical studies on ZYO1 have reported findings which indicate a molecule with superior pre-clinical profile and better safety profile. Mr Pankaj Patel, Chairman and Managing Director, Zydus Cadila, said, ZYO1, the fourth NCE, holds promising commercial potential due to unmet medical needs and absence of effective treatments for obesity and related disorders.

The World Health Organisation (WHO) describes obesity as "one of the greatest public health challenges of the 21st century". It is also a major risk factor for type-II diabetes and cardiovascular disease. According to a WHO estimate, more than one billion people worldwide are over-weight of which at least 300 million are clinically obese. Zydus Cadila plans to initiate Phase I clinical trials to ensure the safety and tolerability of ZYO1. Once the safety of the drug is established the company plans to develop it further to treat various cardio-metabolic risk factors in patients with obesity and prove its beneficial effects in improving HbA1c, HDL-cholesterol, triglycerides, systolic blood pressure and reducing waist circumference, the release added.

More Stories on : Announcements | Pharmaceuticals | Health

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Piaggio set to roll out LCV in January


Zydus files application for obesity drug
HiMedia to distribute VWR products
Carrier India hikes AC prices
Dr Reddy's files prospectus for issue of ADS
`Offshore financing growing 51 pc'
Award for Ion Exchange
Tata's learning experience with acquisition
Going beyond the obvious equation

ICWAI objects to draft guidelines proposals
Tata Sons sells 0.86% in TCS
United Phosphorus buys French co
Bidding discipline in cricket rights
TV 18 acquires Crisil MarketWire
Coal liquefaction: Oil India plans second pilot project
A tale of 2 projects off Kakinada coast
Eco concerns over Jindal project
Sandvik Asia new facility in Hyderabad
OVL-led consortium strikes oil in Iran
HDFC opens London office
Aurobindo to divest Chinese arm holding
5.8 m hits a day at Ministry of Company Affairs portal
Tata Ind in informal talks with RBI
Xenitis Group motorbikes in Jan
Rashtriya Ispat chalks out plan to source iron ore


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line